Single-Cell Genome Sequencing Market Revenue Drivers Growth Opportunities Supply Chain Analysis and Forecast Research Report Till 2025
“The global single-cell genome sequencing market size is expected to reach USD 2.49 billion by 2025 with CAGR of 14.6% in the upcoming period as the scope, product types and its applications are increasing across the globe.”
The global Single-Cell Genome Sequencing Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development. Market Overview: The global single-cell genome sequencing market size is expected to reach USD 2.49 billion by 2025. Single-cell genome sequencing implies analyzing the sequence data with enhanced next-generation sequencing proficiency from a cell. It is a potent instrument that aims to offer intelligence and understanding of genetics by carrying the examination of genomes to the cellular stage. Key Players:
Fludigim QIAGEN Illumina F Hoffmann-La Roche Ltd. ThermoFisher Scientific, Inc. Bio-Rad 10X Genomics, Inc. BD Oxford Nanopore Technologies BGI